Apheresis: (Principle & Clinical Applications)

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 35

APHERESIS

(Principle & Clinical Applications)

Teguh Triyono
Bagian Patologi Klinik/ UPTD
FK UGM/ RSUP Dr Sardjito
Apheresis
 Derived from Greek word “Phaeresis” which means
“taking away”

 Apheresis constitutes a number of procedures in which


donor/patient blood is processed to remove or
manipulate a specific portion of blood.

 The remaining blood is returned back to the


donor/patient
 A prefix added to the term
‘Apheresis’ indicates what is
being removed, such as
– Plateletpheresis (Platelets)
– Leukapheresis (Leukocytes)
– Stemcellapheresis
– Lymphocytapheresis
– Monocytapheresis
– Granulocytapheresis
– erythrocytapheresis
– Plasmapheresis (Plasma)
Principle apheresis

• Filtration techniques

• Centrifuge techniques

• Combinations

4
Separation by gradients

Specific weight
5
Blood
Plasma

Trombocytes

Leukocytes

Erytrocytes

6
Separation in the system

Plasma

Trombocytes
Lymphocytes
Monocytes
} Granulocytes

Erytrocytes

7
Centrifuge channel

8
Centrifuge channel and ‘RPM’

PHTDI, April 2013 9


10
Cell selection

11
Methods of Apheresis :
 Conventional/ manual

 Automatic/ Cell Separator Machines

- Intermittent flow separation


- Continuous flow separation
Automated Separation
 Centrifugation : depend on specific
gravities of the components
 Filtration : Pore size
Separation based on specific weight / size
Spec Weight (g/mL) Size (µm
• Plasma 1.026
• Platelets 1.040 1-4
• Lymphocytes 1.050-1.061 6-10
• Monocytes 1.077 10-30
• Granulocytes 1.080 -1.088 10-15
• Erytrocytes 1.093-1.100 6-8
Apheresis equipment

15
Apheresis procedures

• Donors • To collect components

• To collect components
• Patients
• To remove components
• To exchange
components

Therapeutic Apheresis
16
Donor Apheresis

• Plasmapheresis

• Cytaferese
- Trombocytapheresis
- Lymphocytapheresis Cell therapy

- Stamcelapheresis
- Monocytapheresis
- Granulocytapheresis
- Erytrocytapheresis 17
Plateletpheresis
 Plateletpheresis : collection of platelets
from a donor with return of donor RBCs

 Plateletpheresis is the most common


application of apheresis
 2 types of platelet components :
- random donor platelets or whole
blood derived platelets
- single donor platelets or apheresis
platelets
PLATELETS
Pooled Platelets

Life span 5 days


Stored at room temperature
Lose function when refrigerated or
transfused into cold patient.
One platelet concentrate : 0.5 x 10e 11
suspended in 50 ml plasma.
pH > 6.5 after 72 hours storage at 22°C
Plateletpheresis (Single Donor Platelet )

2 to 5 x 10e11 platelet yield


30% drop in donor platelet count
replaced in 48 hours
Low white cell contamination
Minimal donor red cell loss
Fewer donor reactions than whole
blood donations.
Pheresis Platelets
o o
Storage: at 20 C to 24 C under
constant agitation. Maximum
storage time = 5 days

Therapeutic dose: between 2.0 – 5.0 x 1011


Platelets = 4-8 whole blood collections.
Pheresis Donation Vs Whole Blood Donation
Pheresis Donation Whole Blood Donation
Blood Cell Separator No specialized equipment
Ave 1.5 to 2 hours 10 mins
No shows, rejections, More uniform work flow
deferrals very costly
Hospital/blood center Mobile collection
By appointment Walk-ins
Lab & medical access Autonomous operation
Risk of blood transfusion
Viral infection Frequency per No. of deaths per
million units millions u.

Hepatitis A 1 0
Hepatitis B 7-32 0-0.14
Hepatitis C 4-36 0.5-17
HIV 0.4-5 0.5-5
HTLV (I/II) 0.5-4 0
Parvovirus B19 100 0
Risk of blood transfusion
Other Risk Factor Frequency per No. of deaths per
million units millions u.
Bacterial 2 0.1-0.25
contamination (Rbc)
Bacterial contam. 83 21
(Platelet)
Acute hemolytic 1-4 0.67
reactions
Delayed hemolytic 1000 0.4
reactions
Trali 200 0.2
Risks of Platelet Transfusion
Contamination of Platelets
The risk of platelet sepsis is greater
with a transfusion of pooled platelet
concentrates from multiple donors
than from a single donor.
Risks of Platelet Transfusion
Platelet transfusion can transmit viral or
bacterial disease.
Contaminating red cells in the product may
transmit malaria.
Graft-versus-host disease (preventable by
irradiation)
Cytomegalovirus (preventable by serological
screening)
Alloimmunization caused by contaminating
white cells.
Risk of Platelet transfusion

Leukocyte removed could possibly prevent all


these problems, but this is not established.
Febrile reactions are common and are reduced
but not totally eliminated by Leukocyte
removal
Platelet themselves may cause fever.
Advantages of Single Donor Platelets Over Pooled
Platelet Concentrate Transfusions

One donor exposure only


For special feature collections (HLA-
matched, CMV-negative)
Lower reaction rate
Lower risk of alloimmunization and
transmission of viruses
Increased donor productivity
Advantages of Single Donor Platelets Over Pooled
Platelet Concentrate Transfusions

One Pretransfusion Test


Lower Cost than Manual Collection
Prompt Transfusion Possible
Less Unit Handling
Compliance with Quality System
Standards
Patient Apheresis (reduction of cells)

• Cytaferese
- Trombocytes
- Lymphoblasts
- Myeloblasts
- Erytrocytes

33
Patient Apheresis (exchange)

• Plasma exchange

• RBC exchange

34
Terimakasih

PHTDI, April 2013

You might also like